Abridge

Abridge is the best-funded and fastest-growing ambient clinical-documentation AI company in the US healthcare market. Founded in 2018 by Dr. Shiv Rao (cardiologist at UPMC) along with Sandeep Konam and Zack Lipton, the Pittsburgh-based company has raised approximately $458 million across multiple funding rounds, with a valuation reaching ~$5 billion in its 2025 Series E led by Lightspeed Venture Partners and IVP. The company is privately held and remains in growth mode.

Abridge's core product is an ambient AI scribe that listens to patient-clinician conversations and produces a structured medical note in real time. The note is automatically formatted to match the structure expected by the clinician's EHR (HPI, ROS, physical exam, assessment, plan), translates patient-friendly language into clinical terminology, and can be customized to match individual physician documentation styles. The product is deployed via the Abridge mobile app and through deep integrations with Epic, Cerner/Oracle Health, and other major EHRs.

The company has won deployments at most of the largest US health systems, including Kaiser Permanente (51-hospital, 12.5M-member integrated delivery network), Mayo Clinic, UPMC, Christus Health, Yale New Haven, Sutter Health, Emory Healthcare, and University of Vermont Health Network. Abridge's differentiation against competitors (Suki, DeepScribe, Augmedix, Microsoft Nuance DAX) centers on accuracy in specialty workflows, ease of EHR integration, and product polish for the physician user. The company has also expanded into specialty-specific models (cardiology, oncology, surgery) and into nursing documentation. Revenue is reportedly in the high tens of millions annually as of 2025, with strong gross margins typical of vertical SaaS.